PubMed دسترسی آزاد

Advances in linear epitope-based subunit vaccines powered by artificial intelligence: current status and challenges.

استودیوی صوتی مقاله

پخش حرفه‌ای فارسی و انگلیسی

در حال بررسی نسخه‌های صوتی ذخیره‌شده…

صوت تولیدشده با هوش مصنوعی است. برای کاربرد علمی یا درمانی، متن و منبع اصلی را بررسی کنید.
خواندن هوشمند فارسی و انگلیسی در حال آماده‌سازی صداهای مرورگر…
تنظیم صدای طبیعی و سرعت

صداهایی که در نامشان «Natural»، «Neural» یا «Online» دیده می‌شود معمولاً طبیعی‌ترند. انتخاب صدا به صداهای نصب‌شده در ویندوز و مرورگر شما بستگی دارد.

چکیده اصلی

In this review, linear epitope-based subunit vaccines are systematically profiled to outline their current developmental status, integrating recent advances in computational immunogenic epitope screening, site-specific chemical modification for stability enhancement, next-generation delivery platform matching, and ongoing clinical translation efforts. Deep learning-based MHC-binding prediction tools including NetMHCpan, MHCflurry 2.0, and MARIA, supported by robust empirical evidence, are rigorously evaluated, with notable improvements observed in the efficiency of identifying B/T cell linear epitopes with high immunogenicity, while it is also noted that the field still faces core bottlenecks such as weak in vivo immunogenicity, rapid enzymatic degradation, and insufficient cross-protection against viral variants. According to this integrative evidence-based assessment, feasible optimization pathways are further outlined, including the synergy between AI-driven epitope structural design and virus-like particle-based delivery systems, to provide practical references for the rational development of next-generation broad-spectrum linear epitope-based vaccines.

متن کامل اصلی

نسخه دارای مجوز در منبع علمی در دسترس است.

لینک مستقیم از metadata منبع گرفته شده و در تب جدید باز می‌شود.

باز کردن متن کامل

کلیدواژه‌ها

HLA presentationimmunoinformaticslinear epitopespeptide vaccinesprecision vaccinologyvaccine delivery
در همین زیرشاخه

مقاله‌های مرتبط

PubMed2026

Barry Bloom and the convergence of immunology, infectious disease, and public health.

In early 2026, the world lost Barry Bloom, a great advocate for public health, an extraordinarily accomplished immunologist, and a science advisor who helped refocus policy on controlling infectious diseases, including neglected diseases such as leprosy. Barry's career took him from a life of laboratory discovery where he was enormously influential in catalyzing the late 20th century shift from studying the immune response of simple mo…

PubMed2026

Trajectories in immunometabolism.

Immunometabolism has rapidly evolved from an emerging area within immunology into a topic that not only impregnates most aspects of immune research but also reveals itself as a defining feature of the immune response. At the European Immunometabolism Conference celebrated in June, we asked some of the speakers to share their personal journey as researchers in this field and what questions they are currently working on.

PubMed2026

Hazy mysteries and the major histocompatibility complex: a journey.

I was pleased to receive an invitation to write a historical perspective on my career. As I understand it, these perspectives aim to illustrate the often-twisted paths to discoveries, the fortuitous events that often enable them, and the pitfalls along the way. At the same time, they can be expected to illustrate the influence of the particular "tastes" and interests of a scientist in the choices that are made along the way and that th…